Phillip Gross's Net Worth

$0

Estimate Recalculated Dec 3, 2025 08:07PM EST

Who is Phillip Gross

Phillip Gross does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ORBCOMM Inc., HeartWare International, Inc., Royalty Pharma plc, Celanese Corp, SELECT COMFORT CORP, MULESOFT, INC, GCM Grosvenor Inc., Solaris Oilfield Infrastructure, Inc., HUBBELL INC, Protagonist Therapeutics, Inc, Mandalay Digital Group, Inc., PUMA BIOTECHNOLOGY, INC., Calithera Biosciences, Inc., CONCERT PHARMACEUTICALS, INC., Advaxis, Inc., Nexvet Biopharma plc, AMCI Acquisition Corp., AMAG PHARMACEUTICALS INC., East Resources Acquisition Co, PACIFIC SUNWEAR OF CALIFORNIA INC, Vitae Pharmaceuticals, Inc, SMART BALANCE, INC., FIVE PRIME THERAPEUTICS INC, CARDIOME PHARMA CORP, Targanta Therapeutics Corp., GENEVA ACQUISITION CORP, ABEONA THERAPEUTICS INC., and EyePoint Pharmaceuticals, Inc..

SEC CIK

Phillip Gross's CIK is 0001403413

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ORBCOMM Inc.

Investor
Updated Aug 13, 2020
Form 4
-1.28%
-100.00K
$4.31
-$431.00K
Aug 13, 2020
7.70M
Sale
Aug 12
Form 3
Aug 13, 2020
7.80M
Form 4
-0.85%
-134.00K
$4.02
-$540.27K
Nov 22, 2019
15.68M
Sale
Nov 20 - Nov 21
Form 3
Nov 12, 2019
7.96M
Showing 4 results

HeartWare International, Inc.

Investor
Updated Aug 04, 2015
Form 4
-3.06%
-110.00K
$91.22
-$10.07M
Aug 04, 2015
3.48M
Sale
Jul 31 - Aug 03
Form 4
-1.50%
-173.27K
$80.68
-$13.98M
Apr 21, 2015
11.34M
Sale
Apr 17 - Apr 21
Form 4
2.62%
100.00K
$76.94
$7.69M
Sep 16, 2014
3.91M
Purchase
Sep 12 - Sep 15
Form 3
Sep 11, 2014
1.91M
Showing 4 results

Royalty Pharma plc

Investor
Updated Dec 18, 2020
Form 4
-15.87%
-7.30M
$43.92
-$320.67M
Dec 18, 2020
38.71M
Sale
Dec 17 - Dec 18
Form 4
832.13%
41.38M
$28.00
$84.00M
Jun 22, 2020
46.35M
Purchase
Jun 18
Form 3
Jun 15, 2020
Showing 3 results

Celanese Corp

Investor
Updated Feb 04, 2009
Form 3
Feb 04, 2009
13.59M
Showing 1 results

SELECT COMFORT CORP

Investor
Updated Feb 11, 2011
Form 4
-3.78%
-213.00K
$10.20
-$2.17M
Feb 11, 2011
5.42M
Sale
Feb 09
Form 4
-5.37%
-319.20K
$10.20
-$3.26M
Feb 08, 2011
5.63M
Sale
Feb 04 - Feb 08
Form 4
-12.73%
-867.80K
$10.08
-$8.75M
Feb 03, 2011
5.95M
Sale
Feb 01 - Feb 03
Form 4
-2.85%
-200.00K
$10.42
-$2.08M
Jan 31, 2011
6.82M
Sale
Jan 27 - Jan 31
Form 4
2.18%
150.00K
$7.22
$1.08M
Mar 26, 2010
7.02M
Purchase
Mar 19
Form 4
1.48%
100.00K
$4.75
$475.00K
Dec 10, 2009
6.87M
Purchase
Dec 08
Form 4
1.52%
200.00K
$1.88
$380.78K
Jul 30, 2009
13.40M
Purchase
Jul 28 - Jul 29
Form 3
Nov 25, 2008
6.57M
Showing 8 results

MULESOFT, INC

Investor
Updated Mar 21, 2017
Form 4
-3.57%
-25.00K
$25.06
-$626.50K
Mar 21, 2017
675.00K
Sale
Mar 17
Form 3
Mar 21, 2017
700.00K
Showing 2 results

GCM Grosvenor Inc.

Investor
Updated May 10, 2023
Form 4
-1.78%
-229.14K
$7.55
-$1.73M
May 10, 2023
12.68M
Sale
May 08 - May 10
Form 4
-3.42%
-315.22K
$7.82
-$2.47M
May 05, 2023
8.91M
Sale
May 03 - May 05
Form 4
-1.65%
-239.51K
$7.99
-$1.91M
Apr 28, 2023
14.32M
Sale
Apr 26 - Apr 28
Form 3
Jul 13, 2021
5.94M
Showing 4 results

Solaris Oilfield Infrastructure, Inc.

Investor
Updated Nov 16, 2017
Form 4
Nov 16, 2017
Form 4
3.06%
75.00K
$11.50
$861.91K
May 16, 2017
2.53M
Purchase
May 12
Form 3
May 16, 2017
1.20M
Showing 3 results

HUBBELL INC

Investor
Updated Apr 28, 2008
Form 4
-0.41%
-3.00K
$49.50
-$148.50K
Apr 28, 2008
724.00K
Sale
Apr 25
Form 3
Apr 28, 2008
727.00K
Form 3
Feb 27, 2008
740.21K
Form 4
-1.78%
-13.21K
$51.35
-$678.28K
Feb 27, 2008
727.00K
Sale
Feb 26
Form 4
-3.26%
-25.00K
$57.04
-$1.43M
Nov 07, 2007
742.00K
Sale
Nov 05
Form 3
Nov 02, 2007
1.63M
Showing 6 results

Protagonist Therapeutics, Inc

Investor
Updated Jan 04, 2018
Form 4
Jan 04, 2018
Form 3
Jun 01, 2017
2.06M
Showing 2 results

Mandalay Digital Group, Inc.

Investor
Updated Mar 15, 2012
Form 3
Mar 15, 2012
10.05M
Showing 1 results

PUMA BIOTECHNOLOGY, INC.

Investor
Updated Jun 12, 2017
Form 4
-3.17%
-247.26K
$80.44
-$19.86M
Jun 12, 2017
7.55M
Sale
Jun 08 - Jun 12
Form 4
-5.80%
-507.13K
$86.43
-$44.54M
Jun 05, 2017
8.23M
Sale
Jun 01 - Jun 05
Form 4
-10.91%
-1.24M
$71.91
-$93.14M
May 26, 2017
10.09M
Sale
May 24 - May 26
Form 4
0.40%
22.55K
$38.92
$877.61K
Nov 12, 2013
5.69M
Purchase
Nov 08
Form 4
5.21%
280.70K
$39.60
$11.12M
Nov 06, 2013
5.66M
Purchase
Nov 05
Form 4
0.89%
140.90K
$40.27
$5.70M
Oct 11, 2013
16.05M
Purchase
Oct 09
Form 4
0.28%
29.56K
$18.98
$561.52K
Dec 20, 2012
10.48M
Purchase
Dec 18
Form 4
0.56%
30.40K
$19.00
$577.55K
Dec 14, 2012
5.47M
Purchase
Dec 12
Form 4
1.38%
140.04K
$18.98
$2.66M
Dec 11, 2012
10.27M
Purchase
Dec 07 - Dec 11
Form 4
13.76%
610.00K
$16.00
$9.76M
Oct 22, 2012
5.04M
Purchase
Oct 18
Form 4/A
5.85%
465.40K
$12.25
$5.81M
Jul 27, 2012
8.42M
Purchase
Jul 25
Form 4
7.73%
604.00K
$12.25
$7.47M
Jul 27, 2012
8.42M
Purchase
Jul 25 - Jul 27
Form 4
4.01%
153.00K
$11.21
$1.72M
Jul 18, 2012
3.97M
Purchase
Jul 16
Form 4
2.40%
178.42K
$11.09
$1.97M
Jul 03, 2012
7.60M
Purchase
Jun 29 - Jul 03
Form 4
0.19%
13.50K
$13.25
$178.88K
May 03, 2012
7.26M
Purchase
May 01 - May 03
Form 4
1.72%
122.19K
$13.43
$1.67M
May 01, 2012
7.22M
Purchase
Apr 26 - Apr 30
Form 4
6.06%
200.00K
$13.97
$2.79M
Apr 26, 2012
3.50M
Purchase
Apr 25
Form 4
3.13%
100.00K
$14.00
$1.40M
Apr 26, 2012
3.30M
Purchase
Apr 24
Form 3
Jan 31, 2012
3.20M
Showing 19 results

Calithera Biosciences, Inc.

Investor
Updated Sep 28, 2017
Form 4
-7.30%
-576.00K
$15.63
-$9.01M
Sep 28, 2017
7.32M
Sale
Sep 26 - Sep 28
Form 4
13.42%
487.80K
$10.25
$5.00M
Mar 24, 2017
4.12M
Purchase
Mar 22
Form 4
15.95%
500.00K
$3.15
$1.58M
Nov 17, 2016
3.64M
Purchase
Nov 16
Form 4
1.76%
106.97K
$6.02
$644.65K
Sep 24, 2015
6.19M
Purchase
Sep 22 - Sep 23
Form 4
1.51%
90.30K
$5.94
$535.53K
Sep 08, 2015
6.05M
Purchase
Sep 03 - Sep 04
Form 4
3.11%
172.13K
$4.99
$907.86K
Aug 28, 2015
5.70M
Purchase
Aug 26 - Aug 28
Form 4
2.28%
181.70K
$6.96
$1.26M
Oct 15, 2014
8.17M
Purchase
Oct 13 - Oct 15
Form 4
44.85%
800.00K
$10.00
$8.00M
Oct 03, 2014
2.58M
Purchase
Oct 01
Form 3
Sep 26, 2014
1.78M
Showing 9 results

CONCERT PHARMACEUTICALS, INC.

Investor
Updated Feb 20, 2014
Form 4
-81.87%
-2.30M
Feb 20, 2014
510.15K
Options
Feb 19 - Feb 20
Form 3
Feb 12, 2014
14.57K
Showing 2 results

Advaxis, Inc.

Investor
Updated Oct 12, 2017
Form 4
-12.77%
-600.00K
$4.30
-$2.58M
Oct 12, 2017
4.10M
Sale
Oct 11
Form 4
-10.92%
-1.24M
$4.45
-$5.47M
Sep 26, 2017
10.11M
Sale
Sep 22 - Sep 26
Form 4
1.29%
300.00K
$14.00
$4.25M
Aug 24, 2015
23.47M
Purchase
Aug 20 - Aug 24
Form 4
9.73%
500.00K
$19.00
$9.50M
May 04, 2015
5.64M
Purchase
Apr 30
Form 4
15.37%
684.76K
$7.50
$5.14M
Feb 20, 2015
5.14M
Purchase
Feb 18
Form 3
Dec 19, 2014
4.45M
Showing 6 results

Nexvet Biopharma plc

Investor
Updated Feb 10, 2015
Form 4
31.43%
275.00K
$10.00
$2.75M
Feb 10, 2015
1.15M
Purchase
Feb 10
Form 3
Feb 04, 2015
Showing 2 results

AMCI Acquisition Corp.

Investor
Updated Dec 03, 2020
Form 4
-56.58%
-1.02M
$12.07
-$12.29M
Dec 03, 2020
781.54K
Sale
Dec 01 - Dec 03
Form 3
Nov 30, 2020
1.80M
Showing 2 results

AMAG PHARMACEUTICALS INC.

Investor
Updated Jan 09, 2015
Form 4
-19.22%
-1.25M
$46.17
-$58.11M
Jan 09, 2015
5.25M
Sale
Jan 07 - Jan 09
Form 4
-0.26%
-10.00K
$26.80
-$268.00K
Sep 26, 2013
3.80M
Disposition
Sep 24
Form 4
-0.24%
-18.50K
$24.94
-$461.73K
Sep 06, 2013
7.63M
Disposition
Sep 04 - Sep 06
Form 4
-0.50%
-38.60K
$24.37
-$933.42K
Sep 03, 2013
7.68M
Disposition
Aug 29 - Sep 03
Form 4
-0.37%
-15.10K
$25.01
-$377.74K
Aug 28, 2013
4.03M
Disposition
Aug 26 - Aug 27
Form 4
-0.54%
-25.40K
$24.03
-$616.44K
Aug 23, 2013
4.71M
Disposition
Aug 21 - Aug 23
Form 4
0.03%
1.10K
$23.50
$25.85K
Aug 08, 2013
3.90M
Acquisition
Aug 06
Form 4
-2.23%
-180.04K
$23.13
-$4.16M
Aug 02, 2013
7.90M
Disposition
Jul 31 - Aug 02
Form 4
-1.21%
-50.00K
$24.00
-$1.20M
May 24, 2013
4.09M
Disposition
May 22
Form 4
9.79%
364.39K
$15.55
$5.67M
Mar 05, 2012
4.09M
Purchase
Mar 01
Form 4
1.15%
47.03K
$15.97
$751.13K
Mar 05, 2012
4.14M
Purchase
Mar 02
Form 4
18.19%
1.00M
$15.77
$15.87M
Nov 02, 2010
6.50M
Purchase
Oct 29 - Nov 01
Form 4
1.90%
100.00K
$42.99
$4.30M
Nov 16, 2009
5.35M
Purchase
Nov 12 - Nov 13
Form 4
24.42%
1.19M
$41.05
$40.83M
Nov 10, 2009
5.11M
Purchase
Nov 06 - Nov 10
Form 4
5.60%
245.09K
$42.04
$10.33M
Nov 05, 2009
4.62M
Purchase
Nov 03 - Nov 05
Form 4
0.52%
11.03K
$25.32
$279.22K
Mar 16, 2009
2.14M
Purchase
Mar 12
Form 4
2.04%
84.61K
$25.46
$2.15M
Mar 11, 2009
4.24M
Purchase
Mar 09 - Mar 11
Form 4
3.36%
133.06K
$29.89
$14.32M
Mar 06, 2009
4.09M
Purchase
Mar 04 - Mar 05
Form 3
Mar 06, 2009
1.91M
Showing 19 results

East Resources Acquisition Co

Investor
Updated Jan 24, 2023
Form 4
-100.00%
-2.35M
$10.21
-$23.98M
Jan 24, 2023
Disposition
Jan 23
Form 3
Jul 27, 2022
2.35M
Showing 2 results

ABEONA THERAPEUTICS INC.

Investor
Updated May 08, 2024
Form 4
2.95M
$4.07
$12.00M
May 08, 2024
2.95M
Purchase
May 07
Form 3
Jul 10, 2023
3.25M
Showing 2 results

PACIFIC SUNWEAR OF CALIFORNIA INC

Investor
Updated Apr 07, 2016
Form 4
-26.80%
-4.82M
$0.10
-$497.49K
Apr 07, 2016
13.17M
Sale
Apr 05 - Apr 06
Form 4
4.29%
800.00K
$7.57
$6.05M
Jul 14, 2008
19.43M
Purchase
Jul 11
Form 4
7.13%
1.15M
$11.92
$13.64M
Jan 11, 2008
17.29M
Purchase
Jan 09 - Jan 11
Showing 3 results

Vitae Pharmaceuticals, Inc

Investor
Updated Sep 16, 2016
Form 4
-30.15%
-1.02M
$20.85
-$21.37M
Sep 16, 2016
2.38M
Sale
Sep 14
Form 3
Mar 28, 2016
3.40M
Showing 2 results

SMART BALANCE, INC.

Investor
Updated Oct 21, 2008
Form 3
Oct 21, 2008
6.83M
Showing 1 results

FIVE PRIME THERAPEUTICS INC

Investor
Updated Oct 19, 2015
Form 4
-1.59%
-125.00K
$27.65
-$3.47M
Oct 19, 2015
7.76M
Sale
Oct 15
Form 3
Sep 02, 2015
2.66M
Showing 2 results

CARDIOME PHARMA CORP

Investor
Updated Apr 16, 2010
Form 4
-8.84%
-650.00K
$7.92
-$5.15M
Apr 16, 2010
6.70M
Sale
Apr 14
Form 4
-6.37%
-500.00K
$7.76
-$3.88M
Apr 07, 2010
7.35M
Sale
Apr 05
Form 4
14.60%
1.00M
$3.92
$3.92M
Apr 13, 2009
7.85M
Purchase
Apr 09
Form 3
Apr 13, 2009
6.85M
Showing 4 results

Targanta Therapeutics Corp.

Investor
Updated Nov 24, 2008
Form 3
Nov 24, 2008
2.75M
Showing 1 results

GENEVA ACQUISITION CORP

Investor
Updated Mar 17, 2008
Form 3
Mar 17, 2008
961.00K
Showing 1 results

EyePoint Pharmaceuticals, Inc.

Investor
Updated Apr 22, 2024
Form 3
Apr 22, 2024
5.16M
Showing 1 results